use molecular probes new primary tumors recurrent tumors gynecologic malignancies first report DNA molecular probe technology recurrent tumor second primary malignancy patient Tumor DNA squamous cell carcinoma cervix time radical hysterectomy Eighteen months squamous cell cancer vaginal apex biopsy DNA Tumor DNA lesions enzyme digestion DNA molecular hybridization human papillomavirus HPV probes lesions positive HPV respective restriction enzyme patterns different HPV genetic arrangements distinctness 